21 CFR 1304.26
§ 1304.26 Additional recordkeeping requirements applicable to drug products containing gamma-hydroxybutyric acid.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 1304.26, § 1304.26 Additional recordkeeping requirements applicable to drug products containing gamma-hydroxybutyric acid, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/91902
- Permanent ID
ys:prov:91902@1- SHA-256
77a77526af89adea18eb1e62ec283752e8cc175c2378b7d27a269f809503419c
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
In addition to the recordkeeping requirements for dispensers and researchers provided in § 1304.22, practitioners dispensing gamma-hydroxybutyric acid that is manufactured or distributed in accordance with an application under section 505 of the Federal Food, Drug, and Cosmetic Act must maintain and make available for inspection and copying by the Attorney General, all of the following information for each prescription:
(a) Name of the prescribing practitioner.
(b) Prescribing practitioner's Federal and State registration numbers, with the expiration dates of these registrations.
(c) Verification that the prescribing practitioner possesses the appropriate registration to prescribe this controlled substance.
(d) Patient's name and address.
(e) Patient's insurance provider, if available.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.